LONDON, March 8, 2021 /PRNewswire/
Nearly 1 in 10 (8%) people with glaucoma surveyed in the UK say COVID-19 has prevented them from managing their condition as normal during the pandemic
[1]
Almost a third (29%) people with glaucoma surveyed in the UK who use prescription eye drops to manage their condition, report not using them as frequently as prescribed
[1]
[2]
People with glaucoma have struggled to access their healthcare treatment during the COVID-19 pandemic, putting them at risk of vision loss and blindness, according to results of a new European survey of 2,010 adults with glaucoma, including 250 UK respondents. Glaucoma is an eye condition that affects about two per cent of the population over 40 in the UK